Accéder au contenu
Merck

17alpha-Dihydroequilenin increases hippocampal dendritic spine density of ovariectomized rats.

Brain research (1997-05-30)
S A Washburn, C E Lewis, J E Johnson, M L Voytko, C A Shively
RÉSUMÉ

The effects of estradiol and 17alpha-dihydroequilenin on the apical dendrite spine density of pyramidal cells of the CA1 region of rat hippocampus were compared. 17alpha-Dihydroequilenin was as effective as estradiol in increasing spine densities relative to controls. 17alpha-Dihydroequilenin is not uterotrophic like estradiol but does have beneficial effects on the cardiovascular system, suggesting that it may be an effective single-agent hormone replacement therapy to treat menopausal symptoms and reduce chronic disease risk in menopausal women.

MATÉRIAUX
Référence du produit
Marque
Description du produit

USP
17α-Dihydroequilin, United States Pharmacopeia (USP) Reference Standard
17α-Dihydroequilin, European Pharmacopoeia (EP) Reference Standard